Why Some Dogs Keep Seizing: Understanding and Managing Refractory EpilepsyJune 1, 2026The severe impact of drug-resistant epilepsy highlights the importance of aiming for complete seizure control in all dogs experiencing seizures. It's crucial to enhance our understanding of the reasons behind drug resistance and how they relate to various causes, progression of the disease, and affected breeds.
SPONSORED CONTENTUncompromising renal + sensitivities care.Managing pain from canine OA doesn’t have to be complicated. Discover an approach that doesn’t just treat pain, but addresses inflammation, too. + Learn More
How AI-Enabled Diagnostic Platforms are Buying Back Time for Veterinarians and CliniciansApril 27, 2026In the right context, AI yields the power to enhance clinical confidence and streamline decision-making – without replacing the human touch that defines the profession.
How artificial intelligence can enhance diagnostic confidenceNovember 1, 2025In the right context, AI yields the power to enhance clinical confidence and streamline decision-making – without replacing the human touch that defines the profession.
Rethinking Our Approach to Canine OA: Treating synovial inflammationOctober 1, 2025It’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
A Simpler Way to Support Clients — And Your Bottom LineAugust 11, 2025How Paw Prosper Rewards is Changing the Way Professionals Recommend Products
A "new frontier" for in-clinic veterinary cancer screeningJuly 7, 2025Cancer screening can be a stressful time for clients. However, deep learning artificial intelligence (AI) is changing the game for cytology. AI Masses – a new addition to Zoetis’s Vetscan Imagyst® platform – offers veterinarians analysis of potentially cancerous cells at the point of care, for more timely and individualized diagnosis and treatment.
A New Way Forward in Canine Osteoarthritis: Targeting Pain and Inflammation at Its SourceJuly 1, 2025The traditional approach to canine osteoarthritis (OA) has largely focused on treatments such as NSAIDs, joint supplements, stem cell, PRP, and anti-nerve growth factor (anti-NGF) injections. This raises a critical question: What if we could do more than manage symptoms? What if we could target the inflammation driving the disease?
